How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

502 results for

Mania Secondary Causes

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Mania Secondary Causes

Mania Secondary Causes Mania Secondary Causes Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Mania Secondary Causes Mania Secondary (...) Causes Aka: Mania Secondary Causes From Related Chapters II. General Consider secondary causes if outside typical ages Onset in pre-pubertal children Onset after age 40 years III. Causes: Drugs of Abuse abuse abuse IV. Causes: Collagen vascular disease V. Causes: Infectious disease Herpes St. Louis (HIV) or ( ) VI. Causes: Endocrine disease VII. Causes: Neurologic disease s s Neoplasms (esp. diencephalic or ) VIII. Causes: Vitamin Deficiency IX. Causes: Medications Neuropsychiatric s Heterocyclic s

2018 FP Notebook

2. Mania Secondary Causes

Mania Secondary Causes Mania Secondary Causes Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Mania Secondary Causes Mania Secondary (...) Causes Aka: Mania Secondary Causes From Related Chapters II. General Consider secondary causes if outside typical ages Onset in pre-pubertal children Onset after age 40 years III. Causes: Drugs of Abuse abuse abuse IV. Causes: Collagen vascular disease V. Causes: Infectious disease Herpes St. Louis (HIV) or ( ) VI. Causes: Endocrine disease VII. Causes: Neurologic disease s s Neoplasms (esp. diencephalic or ) VIII. Causes: Vitamin Deficiency IX. Causes: Medications Neuropsychiatric s Heterocyclic s

2015 FP Notebook

3. Relationship between photoperiod and hospital admissions for mania in New South Wales, Australia. (PubMed)

Relationship between photoperiod and hospital admissions for mania in New South Wales, Australia. Causes for a seasonal impact on admissions for mania remain to be clarified. We examined the impact of photoperiod, rate of change of photoperiod and hours of sunshine on admissions over an extended period.Monthly admission data to NSW psychiatric hospitals for more than twenty thousand patients admitted for mania over a fifteen-year period were correlated with photoperiod and sunshine (...) for a distinctive 20% of the variance in hospital admissions.Validity of mania diagnoses cannot be established from the data set, admission data were obtained from across the state while meteorological data were obtained from the capital city, lag periods between onset of a mania and hospitalization (while identified) would impact on associations, social factors were not included and study associations do not imply causality.The lack of a strong year-long correlation may reflect photoperiod changes being only

2017 Journal of Affective Disorders

4. Antibiotics and mania: A systematic review. (PubMed)

Antibiotics and mania: A systematic review. Mania can occur secondary to a medical condition and can be elicited by various pharmacological treatments, both in patients with or without a history of affective disorder. Antibiotic-induced mania or antibiomania is suggested to be a rare phenomenon. We reviewed the literature in order to collect published reports of antibiomania and to summarize new insights about its mechanism and management.We performed a MEDLINE-search and used manual cross (...) -referencing for reports of antibiotic-induced mania and included cases in which a (hypo)manic episode was diagnosed in close temporal relationship with the prescription of an antibiotic.47 cases were published. Patients' ages ranged from 3 to 77 years (mean 40). Two-thirds of the cases were male. Twelve different anti-bacterial agents were implicated, with antitubercular agents, macrolides and quinolones being the most common causative groups.Antibiotic treatment can be associated with (hypo)mania

2017 Journal of Affective Disorders

5. Athanasios Koukopoulos’ Psychiatry: The Primacy of Mania and the Limits of Antidepressants (PubMed)

Athanasios Koukopoulos’ Psychiatry: The Primacy of Mania and the Limits of Antidepressants Athanasios Koukopoulos provided a radical model for understanding depressive and manic conditions.To review, explain, and analyze Koukopoulos' concept of the primacy of mania, with special attention to the role of antidepressants.A conceptual review of Koukopoulos' writings and lectures on this topic is given.Koukopoulos held that depressive states are caused by manic states; the former do not occur (...) in this model. We provide evidence that supports this view in most persons with depressive states.Koukopoulos' model of affective illness is one where manic states are the primary pathology, and depressive conditions are a secondary consequence. Hence treatment of depression with antidepressants would be less effective than treatment with mood stabilizers, since treating an effect is less successful than treating its cause. This approach would reverse current assumptions in psychiatry.

Full Text available with Trip Pro

2017 Current neuropharmacology

6. Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I. (PubMed)

-BP score changes for mania and overall bipolar illness indicate a significant improvement in patient symptomatology for the ESL 800-2400mg group (from preceding and worst phase) and for ESL 600-1800mg group (from worst phase only) when compared to placebo. Study BIA-2093-204 (n=38) results were inconclusive due to premature termination caused by recruitment difficulties. In study BIA-2093-205 (n=85, ITT), at least 50% of patients showed no worsening in all treatment groups (p=0.250). ESL adverse (...) Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I. Eslicarbazepine acetate (ESL) is an anticonvulsant approved as an adjunctive therapy in adults with partial-onset seizures.To evaluate the efficacy, safety and tolerability of ESL in the treatment of acute mania and prevention of recurrence in bipolar disorder I.Two 3

2015 Journal of Affective Disorders

7. Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: Experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I. (PubMed)

-BP score changes for mania and overall bipolar illness indicate a significant improvement in patient symptomatology for the ESL 800-2400mg group (from preceding and worst phase) and for ESL 600-1800mg group (from worst phase only) when compared to placebo. Study BIA-2093-204 (n=38) results were inconclusive due to premature termination caused by recruitment difficulties. In study BIA-2093-205 (n=85, ITT), at least 50% of patients showed no worsening in all treatment groups (p=0.250). ESL adverse (...) Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: Experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I. Eslicarbazepine acetate (ESL) is an anticonvulsant approved as an adjunctive therapy in adults with partial-onset seizures.To evaluate the efficacy, safety and tolerability of ESL in the treatment of acute mania and prevention of recurrence in bipolar disorder I.Two 3

2015 Journal of Affective Disorders

8. Mood Stabilizers and Antipsychotics for Acute Mania: A Systematic Review and Meta-Analysis of Combination/Augmentation Therapy Versus Monotherapy. (PubMed)

monotherapy in 14 trials (n = 3,651) and with AP monotherapy in 6 trials (n = 606) [one study compared combination therapy versus both MS monotherapy and AP monotherapy].The primary outcomes were the mean change scores on validated rating scales for mania and all-cause discontinuation at 3 weeks. The secondary outcomes included response, remission, the mean change scores for depression, dropouts due to adverse events and to inefficacy, and adverse events at 3 weeks and mean change scores on validated (...) Mood Stabilizers and Antipsychotics for Acute Mania: A Systematic Review and Meta-Analysis of Combination/Augmentation Therapy Versus Monotherapy. Pharmacotherapy remains the mainstay of treatment for acute bipolar mania, but there are many choices, including mood stabilizers (MSs) and antipsychotics (APs).To provide an up-to-date and comprehensive review of the efficacy, acceptability and adverse effects of MSs and APs as combination or augmentation therapy versus monotherapy with either drug

2014 CNS drugs

9. Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania

17, 2015 Sponsor: Guiyun Xu Collaborator: The University of Hong Kong Information provided by (Responsible Party): Guiyun Xu, Guangzhou Psychiatric Hospital Study Details Study Description Go to Brief Summary: Background: Bipolar disorder is one of the most common mental illnesses affecting 1%-4% of the population, and one of the leading causes of worldwide disability. Mania is a condition of excessively elevated mood, characterizes bipolar disorder, and usually is a main cause of hospitalization (...) week). If the first attempted antimanic drug fails, psychiatrist need the evidence that which medication should be to added on or switch to. Objectives: one main aim is to rank the short-term ( e.g.one and two week) effectiveness and acceptability of the common anti-mania drugs, including Lithium, Valproate, Oxcarbazepine, Quetiapine, Olanzapine, or Ziprasidone. Secondary aim is to investigate which medication to add on for non-responders or switch to. Methods: The study setting: it is expected

2013 Clinical Trials

10. Mania

symptoms ( ). Treatment [ ] Before beginning treatment for mania, careful must be performed to rule out secondary causes. The acute treatment of a manic episode of involves the utilization of either a (valproate, lithium, lamotrigine, or carbamazepine) or an (olanzapine, quetiapine, risperidone, or aripiprazole). Although episodes may respond to a mood stabilizer alone, full-blown episodes are treated with an (often in conjunction with a mood stabilizer, as these tend to produce the most rapid (...) is a syndrome with multiple causes. Although the vast majority of cases occur in the context of , it is a key component of other psychiatric disorders (such as , bipolar type) and may also occur secondary to various general medical conditions, such as ; certain medications may perpetuate a manic state, for example ; or substances of abuse, such as , or anabolic steroids. [ ] In the current , hypomanic episodes are separated from the more severe full manic episodes, which, in turn, are characterized

2012 Wikipedia

11. Attention deficit hyperactivity disorder: diagnosis and management

for transition between child and adult services produce local protocols for shared care arrangements with primary care providers, and ensure that clear lines of communication between primary and secondary care are maintained ensure age-appropriate psychological services are available for children, young people and adults with ADHD, and for parents or carers. Attention deficit hyperactivity disorder: diagnosis and management (NG87) © NICE 2019. All rights reserved. Subject to Notice of rights (https (...) for assessment for ADHD they may be more likely to have undiagnosed ADHD they may be more likely to receive an incorrect diagnosis of another mental health or neurodevelopmental condition. [2018] [2018] T o find out why the committee made the 2018 recommendations on recognition and how they might affect practice, see rationale and impact. Identification and referr Identification and referral al 1.2.3 Universal screening for ADHD should not be undertaken in nursery, primary and secondary schools. [2008] [2008

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

12. Valproate Use In Women and Girls Of Childbearing Years

for healthcare professionals to know – but it is also important for them to know how to implement this change and work differently. I am very pleased that the Medical Royal Colleges have come together to produce this important and helpful guidance, so that doctors and other healthcare professionals across primary and secondary care are on the same page regarding the use of sodium valproate - including around instances where its use is still appropriate. I hope this new guidance will provide clarity (...) . It is important to recognise that these discussions in themselves are difficult and can cause psychological distress for any party involved. 5.8.2 With mental capacity Girls and women with mild ID and mental capacity should be involved in the discussion wherever possible. Careful evaluation will be required in this setting: the PPP and ARAF will be necessary if there is judged to be childbearing potential. Capacity needs to be considered in each individual situation e.g. consent to have sex is not the same

2019 Royal College of Obstetricians and Gynaecologists

13. Addressing unwarranted variation in healthcare

Addressing unwarranted variation in healthcare Addressing unwarranted variation in healthcare An Evidence Check rapid review brokered by the Sax Institute for Cancer Institute NSW. March 2019 An Evidence Check rapid review brokered by the Sax Institute for Cancer Institute NSW. March 2019. This report was prepared by: Reema Harrison, Elizabeth Manias, Steven Mears, Reece Hinchcliff, David Heslop. UNSW Sydney, March 2019 © Sax Institute 2019 This work is copyright. It may be reproduced in whole (...) or in part for study training purposes subject to the inclusions of an acknowledgement of the source. It may not be reproduced for commercial usage or sale. Reproduction for purposes other than those indicated above requires written permission from the copyright owners. Enquiries regarding this report may be directed to the: Principal Analyst Knowledge Exchange Program Sax Institute www.saxinstitute.org.au knowledge.exchange@saxinstitute.org.au Phone: +61 2 91889500 Suggested Citation: Harrison R, Manias

2019 Sax Institute Evidence Check

14. Diagnosis and management of gonorrhoea and syphilis

and epidemiological trends 1.1.1.1 Gonorrhoea Gonorrhoea is caused by the Gram-negative bacterium Neisseria gonorrhoeae (N. gonorrhoea) with infection of the columnar epithelium of the urethra, endocervix, rectum, pharynx and conjunctivae. 2 Symptoms and physical signs of gonorrhoea constitute of a localised in?ammation of the infected mucosal surfaces. In men, the presentation is mostly of acute urethritis with symptoms of mucopurulent urethral discharge (80%) and dysuria (50%), usually starting within 2–8 days (...) of exposure. Asymptomatic urethral infection is uncommon in men (less than 10% of urethral infections). 2 In women, genital tract symptoms include increased or altered vaginal discharge (50%), lower abdominal pain (25%), dysuria (10–15%) and rarely intermenstrual bleeding or menorrhagia. Endocervical infection is asymptomatic in half of the cases. Rectal and pharyngeal infections are usually asymptomatic. 2 Complications can occur when the infection causes severe local symptoms of cervicitis, urethritis

2019 Belgian Health Care Knowledge Centre

15. Lithium

are conflicting and limited. Methods We conducted a cohort study involving 1,325,563 pregnancies in women who were enrolled in Medicaid and who delivered a live-born (...) infant between 2000 and 2010. We examined the risk of cardiac malformations among infants exposed to lithium during the first trimester as compared with unexposed infants and, in secondary analyses, with infants exposed to another commonly used mood stabilizer, lamotrigine. Risk ratios and 95% confidence intervals were estimated (...) the prevention of severe affective episodes and suicide. METHODS: Retrospective cohort study in the Swedish region of Norrbotten into the causes of lithium discontinuation (...) . The study was set up to (1) test whether patients with bipolar affective disorder or schizoaffective disorder, treated with lithium maintenance therapy, were more likely to discontinue lithium because of adverse effects than lack of therapeutic effectiveness, (2) explore gender differences, (3) understand the role of diagnosis

2018 Trip Latest and Greatest

17. Mindfulness-based stress reduction (MBSR) for improving health, quality of life and social functioning in adults

mindfulness. What is this review about? Stress and stress-related mental health problems are major causes of illness and disability. MBSR is a group-based health promotion intervention to improve health and the way people deal with stress and life’s challenges. The core ingredient is mindfulness training through physical and mental exercises practiced daily for eight weeks. The mindful non-judgmental attitude of being present with what arises is practiced in the formal exercises and in everyday situations (...) and mild to moderate psychological problems are high among children, adolescents and adults alike, and chronic musculoskeletal pain is widespread. While our understanding of these mass phenomena is limited, stress is probably both a cause and a consequence. Stress is also part of our working life. In surveys carried out every five years in the EU, the respondents name stress as the second most common threat posed by the working environment, affecting a fifth of the work-force at any time (European Risk

2017 Campbell Collaboration

19. Identifying and Assessing Core Components of Collaborative-care Models for Treating Mental and Physical Health Conditions

and physical health conditions? Why the issue is important • Projections of global mortality and burden of disease shows that mental illness and non-communicable diseases will continue to be the leading causes of mortality and morbidity across the globe. • Rates of multimorbidity in individuals are also increasing, and in circumstances where the mix of conditions includes both mental health and physical health problems, the outcomes and experiences tend to be worse for individuals and costly for the system (...) will continue to be among the leading causes of mortality and morbidity across the globe.(1) Furthermore, most people with chronic conditions are living with multiple chronic conditions (often referred to as multimorbidity).(2) In general, people living with multiple chronic conditions have greater healthcare needs and use more services, but have worse health and social outcomes (e.g., quality of life, ability to work, employability, disability and mortality) than the general population.(3) Patterns

2017 McMaster Health Forum

20. Outcome Measures Framework: Information Model Report

maximum and minimum, duration follow up, condition, primary outcome measures, and secondary outcome measures. A field was considered required if it is required to complete and post a record into the ClinicalTrials.gov database. The fields that were required were: brief title, sponsor type, intervention type, study design, study status, time perspective, enrollment, age, duration follow up, at least one condition, and one outcome measure. These fields were examined to determine whether they had been (...) % Behavioral 14 0.9 Biological 11 0.7 Device 150 9.7 Dietary Supplement 4 0.3 Drug 94 6.1 Genetic 8 0.5 Other 190 12.3 Procedure 109 7.1 Radiation 18 1.2 Missing 947 61.3 The distribution of primary and secondary outcomes is shown in Table 3. In ClinicalTrials.gov, one outcome is required. There were 1,305 (84.5%) records with only one outcome, 236 (15.3%) with two or more, 119 (7.7%) with three or more, and 69 (4.5%) with four or more. Fewer records listed secondary outcome measures, likely due

2018 Effective Health Care Program (AHRQ)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>